264 related articles for article (PubMed ID: 20662794)
1. Long-term survival after surgical management of neuroendocrine hepatic metastases.
Glazer ES; Tseng JF; Al-Refaie W; Solorzano CC; Liu P; Willborn KA; Abdalla EK; Vauthey JN; Curley SA
HPB (Oxford); 2010 Aug; 12(6):427-33. PubMed ID: 20662794
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
Mazzaglia PJ; Berber E; Milas M; Siperstein AE
Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection.
Taner T; Atwell TD; Zhang L; Oberg TN; Harmsen WS; Slettedahl SW; Kendrick ML; Nagorney DM; Que FG
HPB (Oxford); 2013 Mar; 15(3):190-5. PubMed ID: 23374359
[TBL] [Abstract][Full Text] [Related]
4. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for neuroendocrine liver metastases: a systematic review.
Mohan H; Nicholson P; Winter DC; O'Shea D; O'Toole D; Geoghegan J; Maguire D; Hoti E; Traynor O; Cantwell CP
J Vasc Interv Radiol; 2015 Jul; 26(7):935-942.e1. PubMed ID: 25840836
[TBL] [Abstract][Full Text] [Related]
6. Surgical strategy for liver metastases of neuroendocrine tumors.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Nakayama T; Tabata Y; Shichinohe T
Hepatogastroenterology; 2012 May; 59(115):921-3. PubMed ID: 22024223
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Sichinohe T
Hepatogastroenterology; 2012; 59(120):2623-6. PubMed ID: 22497945
[TBL] [Abstract][Full Text] [Related]
10. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
[TBL] [Abstract][Full Text] [Related]
11. T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases.
Katz SC; Donkor C; Glasgow K; Pillarisetty VG; Gönen M; Espat NJ; Klimstra DS; D'Angelica MI; Allen PJ; Jarnagin W; Dematteo RP; Brennan MF; Tang LH
HPB (Oxford); 2010 Dec; 12(10):674-83. PubMed ID: 21083792
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience.
Kose E; Kahramangil B; Aydin H; Donmez M; Takahashi H; Aucejo F; Siperstein A; Berber E
Surg Endosc; 2020 Jan; 34(1):249-256. PubMed ID: 30945061
[TBL] [Abstract][Full Text] [Related]
13. Cryoablation and liver resection for noncolorectal liver metastases.
Goering JD; Mahvi DM; Niederhuber JE; Chicks D; Rikkers LF
Am J Surg; 2002 Apr; 183(4):384-9. PubMed ID: 11975925
[TBL] [Abstract][Full Text] [Related]
14. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.
Grazi GL; Cescon M; Pierangeli F; Ercolani G; Gardini A; Cavallari A; Mazziotti A
Hepatogastroenterology; 2000; 47(32):481-6. PubMed ID: 10791218
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for metastatic neuroendocrine tumors.
Lang H; Oldhafer KJ; Weimann A; Schlitt HJ; Scheumann GF; Flemming P; Ringe B; Pichlmayr R
Ann Surg; 1997 Apr; 225(4):347-54. PubMed ID: 9114792
[TBL] [Abstract][Full Text] [Related]
16. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
17. Management of Neuroendocrine Tumor Liver Metastases: Long-Term Outcomes and Prognostic Factors from a Large Prospective Database.
Fairweather M; Swanson R; Wang J; Brais LK; Dutton T; Kulke MH; Clancy TE
Ann Surg Oncol; 2017 Aug; 24(8):2319-2325. PubMed ID: 28303430
[TBL] [Abstract][Full Text] [Related]
18. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
[TBL] [Abstract][Full Text] [Related]
19. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
[TBL] [Abstract][Full Text] [Related]
20. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
